Recommended Final Dividend for the financial year ended March 31, 2026, subject to approval of the shareholders in the forthcoming 41st Annual General Meeting of the Company
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma's Board has recommended a final dividend of Rs. 1 per share (100% on face value of Rs. 1) for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the 41st AGM scheduled for July 15, 2026. For the year, the company reported standalone net profit of Rs. 3,242.25 lakh and consolidated net profit of Rs. 9,685.44 lakh. The company has also reappointed BDO India Services Private Limited as internal auditor for FY 2026-27. The audited results received an unmodified opinion from statutory auditors Kalyaniwalla & Mistry LLP.
The dividend declaration signals the company's financial health and cash generation ability. Shareholders can expect the dividend payout after the AGM approval, though the per-share amount of Rs. 1 is modest given the Rs. 1 face value.